StockHealthcare · Biotechnology

$DMAC

DiaMedica Therapeutics Inc.

Price · $DMACvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $DMAC in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $DMAC in the last 30 days.

EBITDA per share of DiaMedica Therapeutics Inc. – NASDAQ:DMAC

This article provides the EBITDA per share information for DiaMedica Therapeutics Inc. (NASDAQ: DMAC). The content appears to be a financial data snippet from TradingView, focusing on key financial metrics for the specified biotechnology company.

SEP 17·Zacks Commentary

DiaMedica Therapeutics, Inc. ( DMAC ) is a Great Momentum Stock: Should You Buy?

Does DiaMedica Therapeutics, Inc. (DMAC) have what it takes to be a top stock pick for momentum investors? Let's find out.

SEP 9·Zacks Commentary

After Golden Cross, DiaMedica Therapeutics, Inc. ( DMAC ) 's Technical Outlook is Bright

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

via TradingView

News on $DMAC

All news →